NPPA issued a notification regarding the fixation and revision of the ceiling price of certain formulations

Aug 08, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on August 06, 2024, issued a notification regarding the fixation and revision of the ceiling price of certain formulations.

The following has been stated namely: -

• For each 100ml containing: Paracetamol Infusion IP the retail price (Rs.) is 3.58.

• For each hard gelatine capsule containing: Atorvastatin Calcium IP eq. to Atorvastatin 10mg (As pellets form), Clopidogrel Bisulphate IP eq. to Clopidogrel 75mg (As pellets form) the retail price (Rs.) is 14.48.

• For each film-coated tablet containing: Dolutegravir Sodium eq. to 50mg of Dolutegravir Tenofovir Alafenamide 25mg (eq. to 28mg of Tenofovir Alafenamide fumarate), Emtricitabine 200mg the retail price (Rs.) is 121.21.

The detailed notification is given in the document below.

[Notification No. S.O. 3169(E)]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT